Obtenga las últimas noticias sobre las acciones de Alterity Therapeutics con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de ATHE

Últimas noticias sobre

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

ALTG

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CARM

CNCK

CRGX

FBNC

MGOL

NAOV

NATR

OFIX

RNGR

SLXN

TSLA

VREX

XFOR

Meta sube en la preapertura tras superar expectativas. Descubre qué otras acciones están registrando fuertes movimientos hoy.

Acciones de Meta Platforms (META) están cotizando al alza; 20 acciones que se mueven en el premercado de EE.UU.

Alterity Therapeutics Ltd

ATHENS INTL ARPT S A by ATHENS INTL ARPT SA

ATHENS INTL ARPT SA U/ADR by ATHENS INTL ARPT SA

ATHENA BITCOIN GLOBAL by ATHENA BITCOIN GLOBAL

Athena Bitcoin Global

Athena Gold Corp

ATHENA GOLD CORP by Athena Gold Corporation

ATHENA TECH ACQ CP II A by Athena Technology Acquisition Corp. II

Athena Technology Acquisition Corp II

ATHENA TECH ACQ CP II UTS by Athena Technology Acquisition Corp. II

Athena Technology Acquisition Corp II Warrants (01/01/9999)

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Share, Series A

Athene Holding Ltd

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 5.625% Fixed Rate Perpetual Non- Cumulative Preference Share, Series B, par value $1.00 per share

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 4.875% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series D

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 7.750% Fixed-Rate Reset Perpetual Non-Cumulative Preference Share, Series E

Athene Holding Ltd. 7.250% Fixed-Rate Reset Junior Subordinated Debentures due 2064

Athenex Inc

ATHENS WTR&SWGE PUB EYDAP by Athens Water & Sewage Public Co. Eydap

Athens Water Supply & Sewerage Co

Athersys Inc

Health Care

Press Releases

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

News

General

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

Alterity Therapeutics Prominently Featured at the International MSA Congress

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

ABVC BioPharma

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Alterity Therapeutics

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

BeyondSpring

Cibus

CervoMed

Elutia

EXoZymes

Insight Molecular Diagnostics Inc. - Common Stock

Insight Molecular

Opus Genetics

Invivyd

MDxHealth

Metagenomi

OKYO Pharma

OS Therapies

Ovid Therapeutics

PMV Pharma

Pyxis Oncology

Repare Therapeutics

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Sutro Biopharma

Whitehawk Therapeutics, Inc. - Common Stock

Comments

Alterity Therapeutics Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL